Stocktoria

Aura Biosciences, Inc. AURA

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-10-29

Aura Biosciences, Inc. statistics & valuation

Market cap$724.1M
P / B5.3×
Return on equity-77.6%
Return on capital-74.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-23.10% -30.00% -33.80% -57.20% -77.60% 202020212022202320242025
Shares outstanding
381123 29.2M 37.8M 49.4M 50.0M 63.6M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-100.50% -22.00% -26.20% -30.00% -47.60% -62.70% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$8.95 -$1.96 -$1.93 -$1.75 -$1.76 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-62.7%-47.6%-30.0%-26.2%-22.0%-100.5%
Return on equity-77.6%-57.2%-33.8%-30.0%-23.1%20.4%
Current ratio8.1510.7718.7618.8120.906.94

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.